Glenmark Pharmaceuticals Limited: corporate announcements

1064 records, the earliest from 27 Oct 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

1064 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DateCategorySubject
28 Sep 2026Insider Trading / SAST Glenmark Pharmaceuticals Ltd - 532296 - Closure of Trading Window
28 Sep 2026
12:46
Trading Window Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
23 Sep 2026
03:11
Press Release Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Goa facility with VAI classification".
21 Sep 2026Company Update Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21 Sep 2026
09:22
Analysts/Institutional Investor Meet/Con. Call Updates Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet
11 Sep 2026Company Update Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
11 Sep 2026Company Update Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
11 Sep 2026AGM/EGM Glenmark Pharmaceuticals Ltd - 532296 - Shareholder Meeting / Postal Ballot-Outcome of AGM
11 Sep 2026AGM/EGM Glenmark Pharmaceuticals Ltd - 532296 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
11 Sep 2026
13:24
Shareholders meeting Glenmark Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 11, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.